Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
CRH French Reference Center for Hemophilia Lyon shared a post on LinkedIn about a recent article by Cedric Hermans et al., published in Blood Reviews, adding:
“Our latest review on bispecific FVIIIa–mimetic antibodies for haemophilia A has just been published.
We discuss the antibodies that are approved or in advanced clinical development, highlighting how they differ in design and in their preclinical and clinical profiles.
Thank you to my co-authors for their collaboration.”
Title: Exploring the evolving landscape of bispecific FVIIIa-mimetic antibodies in haemophilia A
Authors: Cedric Hermans, Janice M. Staber, Priyanka Raheja, Michaela Lehle, Anna Kiialainen, Christophe Schmitt, Dan Hart, Matthew Locke, Davide Matino, Yesim Dargaud

Other posts featuring CRH French Reference Center for Hemophilia Lyon on Hemostasis Today.
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series
-
Nov 20, 2026, 17:16Raising Awareness of Bleeding Disorders in Women Through the Red Flag Campaign – Perth Blood Institute
-
Nov 20, 2026, 15:11Muhammet Özbilen: Rivaroxaban vs Apixaban – The Menstrual Bleeding Difference